These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8017724

  • 1. Superinfection with rifampin-isoniazid-streptomycin-ethambutol (RISE)-resistant tuberculosis in three patients with AIDS: confirmation by polymerase chain reaction fingerprinting.
    Horn DL, Hewlett D, Haas WH, Butler WR, Alfalla C, Tan E, Levine A, Nayak A, Opal SM.
    Ann Intern Med; 1994 Jul 15; 121(2):115-6. PubMed ID: 8017724
    [No Abstract] [Full Text] [Related]

  • 2. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
    Ndung'u PW, Kariuki S, Ng'ang'a Z, Revathi G.
    J Infect Dev Ctries; 2012 Jan 12; 6(1):33-9. PubMed ID: 22240426
    [Abstract] [Full Text] [Related]

  • 3. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD.
    Microb Drug Resist; 2010 Mar 12; 16(1):21-8. PubMed ID: 20001742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
    Golyshevskaia VI, El'shanskaia MP.
    Probl Tuberk; 1973 Mar 12; 51(12):60-4. PubMed ID: 4205666
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K, N'Dathz M, Yapi A.
    Rev Mal Respir; 2000 Apr 12; 17(2):477-80. PubMed ID: 10859766
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The antituberculosis efficacy of rifampin in 136 patients.
    Davidson PT, Goble M, Lester W.
    Chest; 1972 Jun 12; 61(6):574-8. PubMed ID: 4624279
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis.
    Nolan CM, Williams DL, Cave MD, Eisenach KD, el-Hajj H, Hooton TM, Thompson RL, Goldberg SV.
    Am J Respir Crit Care Med; 1995 Sep 12; 152(3):1067-71. PubMed ID: 7663785
    [Abstract] [Full Text] [Related]

  • 16. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug 04; 37(954):67-70. PubMed ID: 7616907
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.